Dimerization of the Glucan Phosphatase Laforin Requires the Participation of Cysteine 329

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Sánchez Martín, Pablo ^a   Raththagala, Madushi ^b   Bridges, Travis M ^b   Husodo, Satrio ^b   Gentry, Matthew S ^b   Sanz, Pascual ^a   Romá Mateo, Carlos ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTEINE; CYSTEINE 329; DIMER; GLUCAN; GLUCAN PHOSPHATASE; LAFORIN; PHOSPHATASE; RECOMBINANT PROTEIN; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNODETECTION; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION STATE; PROTEIN FUNCTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; UBIQUITINATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CARBOHYDRATE METABOLISM; CARRIER PROTEINS; CYSTEINE; GLUCANS; HEK293 CELLS; HUMANS; MAMMALS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84880839474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069523     Document Type: Article

References (57)

1. Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, et al. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20: 171-174.
2. Serratosa JM, Gomez-Garre P, Gallardo ME, Anta B, de Bernabe DB, et al. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8: 345-352.
3. Monaghan TS, Delanty N, (2010) Lafora disease: epidemiology, pathophysiology and management. CNS Drugs 24: 549-561.
4. Minassian BA, (2001) Lafora's disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 25: 21-29.
5. Rao SN, Maity R, Sharma J, Dey P, Shankar SK, et al. (2010) Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin. Hum Mol Genet 19: 4726-4734.
6. Worby CA, Gentry MS, Dixon JE, (2006) Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J Biol Chem 281: 30412-30418.
7. Tagliabracci VS, Turnbull J, Wang W, Girard JM, Zhao X, et al. (2007) Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc Natl Acad Sci U S A 104: 19262-19266.
8. Gentry MS, Dixon JE, Worby CA (2009) Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem Sci.
9. Gentry MS, Dowen RH 3rd, Worby CA, Mattoo S, Ecker JR, et al (2007) The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease. J Cell Biol 178: 477-488.
10. Wang W, Parker GE, Skurat AV, Raben N, DePaoli-Roach AA, et al. (2006) Relationship between glycogen accumulation and the laforin dual specificity phosphatase. Biochem Biophys Res Commun 350: 588-592.
11. Roach PJ, (2011) Are there errors in glycogen biosynthesis and is laforin a repair enzyme? FEBS Letters 585: 3216-3218.
12. Sakai M, Austin J, Witmer F, Trueb L, (1970) Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 20: 160-176.
13. Schnabel R, Seitelberger F, (1968) Histophysical and histochemical investigations of myoclonus bodies. Pathol Eur 3: 218-226.
14. Tagliabracci VS, Girard JM, Segvich D, Meyer C, Turnbull J, et al. (2008) Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem 283: 33816-33825.
15. Tagliabracci VS, Heiss C, Karthik C, Contreras CJ, Glushka J, et al. (2011) Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab 13: 274-282.
16. Nitschke F, Wang P, Schmieder P, Girard JM, Awrey DE, et al. (2013) Hyperphosphorylation of glucosyl c6 carbons and altered structure of glycogen in the neurodegenerative epilepsy lafora disease. Cell Metab 17: 756-767.
17. Gentry MS, Romá-Mateo C, Sanz P (2012) Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. Febs J.
18. Romá-Mateo C, Sanz P, Gentry MS, (2012) Deciphering the role of malin in the lafora progressive myoclonus epilepsy. IUBMB Life 64: 801-808.
19. Chan EM, Bulman DE, Paterson AD, Turnbull J, Andermann E, et al. (2003) Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet 40: 671-675.
20. Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, et al. (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 35: 125-127.
21. Gentry MS, Worby CA, Dixon JE, (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci U S A 102: 8501-8506.
22. Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, et al. (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10: 1407-1413.
23. Cheng A, Zhang M, Gentry MS, Worby CA, Dixon JE, et al. (2007) A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease. Genes Dev 21: 2399-2409.
24. Rubio-Villena C, Garcia-Gimeno MA, Sanz P (2013) Glycogenic activity of R6; a protein phosphatase 1 regulatory subunit; is modulated by the laforin-malin complex. Int J Biochem Cell Biol.
25. Solaz-Fuster MC, Gimeno-Alcaniz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, et al. (2008) Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet 17: 667-678.
26. Sengupta S, Badhwar I, Upadhyay M, Singh S, Ganesh S, (2011) Malin and laforin are essential components of a protein complex that protects cells from thermal stress. J Cell Sci 124: 2277-2286.
27. Rao SN, Sharma J, Maity R, Jana NR, (2010) Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease. J Biol Chem 285: 1404-1413.
28. Mittal S, Dubey D, Yamakawa K, Ganesh S, (2007) Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment. Hum Mol Genet 16: 753-762.
29. Aguado C, Sarkar S, Korolchuk VI, Criado O, Vernia S, et al. (2010) Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum Mol Genet 19: 2867-2876.
30. Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, et al. (2012) Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum Mol Genet 21: 1521-1533.
31. Puri R, Ganesh S, (2010) Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease? Autophagy 6: 1229-1231.
32. Vernia S, Rubio T, Heredia M, Rodriguez de Cordoba S, Sanz P, (2009) Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. PLoS One 4: e5907.
33. Alonso A, Rojas A, Godzik A, Mustelin T (2004) The dual-specific protein tyrosine phosphatase family. In: Ariño J, & Alexander, D.R., editor. Topics in Current Genetics: Protein Phosphatases. Heidelberg: Springer Berlin. 333-358.
34. Pulido R, Hooft van Huijsduijnen R, (2008) Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease. Febs J 275: 848-866.
35. Wang J, Stuckey JA, Wishart MJ, Dixon JE, (2002) A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J Biol Chem 277: 2377-2380.
36. Ganesh S, Agarwala KL, Ueda K, Akagi T, Shoda K, et al. (2000) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum Mol Genet 9: 2251-2261.
37. Liu Y, Wang Y, Wu C, Zheng P, (2006) Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling. J Biol Chem 281: 34768-34774.
38. Dukhande VV, Rogers DM, Romá-Mateo C, Donderis J, Marina A, et al. (2011) Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PLoS One 6: e24040.
39. Romá-Mateo C, Solaz-Fuster Mdel C, Gimeno-Alcaniz JV, Dukhande VV, Donderis J, et al. (2011) Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase. Biochem J 439: 265-275.
40. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
41. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 95-98.
42. Sorimachi K, Le Gal-Coeffet MF, Williamson G, Archer DB, Williamson MP, (1997) Solution structure of the granular starch binding domain of Aspergillus niger glucoamylase bound to beta-cyclodextrin. Structure 5: 647-661.
43. Vander Kooi CW, Taylor AO, Pace RM, Meekins DA, Guo HF, et al. (2010) Structural basis for the glucan phosphatase activity of Starch Excess4. Proc Natl Acad Sci U S A 107: 15379-15384.
44. Pei J, Kim BH, Grishin NV, (2008) PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res 36: 2295-2300.
45. Arnold K, Bordoli L, Kopp J, Schwede T, (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201.
46. Luthy R, Bowie JU, Eisenberg D, (1992) Assessment of protein models with three-dimensional profiles. Nature 356: 83-85.
47. Christen M, Hunenberger PH, Bakowies D, Baron R, Burgi R, et al. (2005) The GROMOS software for biomolecular simulation: GROMOS05. J Comput Chem 26: 1719-1751.
48. Vernia S, Solaz-Fuster MC, Gimeno-Alcaniz JV, Rubio T, Garcia-Haro L, et al. (2009) AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex. J Biol Chem 284: 8247-8255.
49. Paumi CM, Menendez J, Arnoldo A, Engels K, Iyer KR, et al. (2007) Mapping protein-protein interactions for the yeast ABC transporter Ycf1p by integrated split-ubiquitin membrane yeast two-hybrid analysis. Mol Cell 26: 15-25.
50. Ludin K, Jiang R, Carlson M, (1998) Glucose-regulated interaction of a regulatory subunit of protein phosphatase 1 with the Snf1 protein kinase in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 95: 6245-6250.
51. Gentry MS, Pace RM, (2009) Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism. BMC Evol Biol 9: 138.
52. Liu Y, Wang Y, Wu C, Zheng P, (2009) Deletions and missense mutations of EPM2A exacerbate unfolded protein response and apoptosis of neuronal cells induced by endoplasm reticulum stress. Hum Mol Genet 18: 2622-2631.
53. Christiansen C, Abou Hachem M, Janecek S, Vikso-Nielsen A, Blennow A, et al. (2009) The carbohydrate-binding module family 20-diversity, structure, and function. Febs J 276: 5006-5029.
54. Dukhande VV, Rogers DM, Romá-Mateo C, Donderis J, Marina A, et al. (2011) Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PLoS One 6: e24040.
55. Sherwood AR, Paasch BC, Worby CA, Gentry MS, (2013) A malachite green-based assay to assess glucan phosphatase activity. Anal Biochem 435: 54-56.
56. Kaiser P, Tagwerker C, (2005) Is this protein ubiquitinated? Methods Enzymol 399: 243-248.
57. Koksal AC, Cingolani G, (2011) Dimerization of Vaccinia virus VH1 is essential for dephosphorylation of STAT1 at tyrosine 701. J Biol Chem 286: 14373-14382.